16 February 2016
New studies have demonstrated the significant benefits that T-cell therapy can provide for sufferers of advanced forms of cancer.
Research results presented at the American Association for the Advancement of Science's annual meeting have indicated that using the body's own immune cells to attack metastatic tumours could represent a major breakthrough in treating serious cancer cases.
In one study, 94 per cent of participants with acute lymphoblastic leukaemia saw their symptoms vanish completely, while patients with other blood cancers had response rates greater than 80 per cent, and more than half experienced complete remission.
Although these positive responses were not always durable and were sometimes followed by relapses, they suggest that this approach could yield much better results than currently available treatment strategies.
Dr Stanley Riddell of the Fred Hutchinson Cancer Research Centre in Seattle said: "These [results] are in patients who have failed everything. Most of the patients in our trial would be projected to have two to five months to live. This is extraordinary."
Posted by Jeanette Royston
Health News is provided by Axonn Media in collaboration with Spire Healthcare. Please note that all copy above is ©Axonn Media and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.